SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

15 Jul 2015 07:00

RNS Number : 0664T
City of London Investment Group PLC
15 July 2015
 

 

City of London Investment Group PLC

15 July 2015



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

 

TRADING UPDATE

 

for the year to 30 June 2015

 

City of London (LSE: CLIG), a leading emerging markets asset management group, provides a trading update for its financial year ended 30 June 2015. The numbers that follow are all unaudited.

 

Funds under management were US$4.2 billion (£2.7 billion) at 30 June 2015 (2014: US$3.9 billion or £2.3 billion), representing an 8% increase in US$ terms and a 17% increase in GBP terms as a result of the cross rate moving from 1.71 to 1.57 over the period. Over the same period the MSCI Emerging Markets Index (MXEF) fell by 5% in US$ terms.

 

For the year to 30 June 2015, City of London expects that pre-tax profits will be approximately £8.8 million (2014: £7.2 million, 13 months), and that profits after an anticipated tax charge of £2.3 million (26% of pre-tax profits) will be approximately £6.5 million (2014: profits of £5.2 million after a tax charge of £2.0 million, representing 28% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 26.1p and 25.7p respectively (2014: 20.7p and 20.6p).

 

The Board is recommending a final dividend of 16p per share (2014: 16p). This would bring the total for the year to 30 June 2015 to 24p (2014: 24p), making cover 1.1 times earnings per share (2014: 0.86 times). As previously announced the Board's dividend policy is based around a cover of 1.2 times earnings on a rolling five year average. The proposed dividend is in-line with this policy.

 

Overheads for the year to 30 June 2015 are expected to be £9.4 million (2014: £10.3 million, 13 months) and the current monthly run-rate is slightly in excess of £0.8m.

 

Investment performance in the emerging markets closed-end fund (CEF) strategy remains strong, with first or second quartile results versus manager peers year to date in 2015. The present wide size-weighted average discount (SWAD) of c12-13% across client portfolios indicates value in the strategy. The investment approach adds value beyond this by exploiting volatility of the underlying discounts in the CEF universe, from which portfolios are constructed with their specific SWAD characteristics.

 

During the period, marketing efforts led to new inflows of $477 million in emerging market strategies, which were countered by outflows of $437 million as investor risk aversion rose due to ongoing volatility in global markets. Fundraising in the diversification products resulted in $255m of new mandates ($100m in Frontier Emerging Markets strategies, and $155m in Global Tactical Asset Allocation strategies) and outflows of $20 million.

 

As noted in the interim statement these wins will assist with efforts to raise the profile of our diversification CEF products with institutional consultants and plan sponsors. Diversification products now represent 8.5% of Group AUM, compared with 2% last year.

 

City of London Investment Group expects to announce final results along with the Accounts for the year to 30 June 2015 on 14 September 2015. The Company's Annual General Meeting date, and final dividend payment dates are expected to be 19 October 2015 and 30 October 2015 respectively. An Investor Day will be held after the Annual General Meeting on 19 October 2015. Details will be included within the Accounts.

 

As a result of increased volatility, Shareholders will see in the Template below that we have reduced our assumptions regarding net new money from mandates next year to $250 million for the emerging market strategy and an additional $250 million in diversification products. Subsequent to the year end, we are aware of new mandates of circa $35 million with deminimis redemptions. As a result of recent volatility we are reviewing our budget for 2015/2016; as shareholders would expect we will be monitoring costs closely as the year progresses. We will continue to update our web site www.citlon.co.uk for the most recent FUM on a monthly basis.

 

Please note that going forward we will not include an estimate for market growth within the Template.

 

Summary and unaudited trading update

Year to

30 June

2015

13 months

to 30 June

2014

 

Funds under Management (at period end)

US$4.2bn

US$3.9bn

 

Turnover (plus investment income)

£25.4m

£24.4m

 

Administrative expenses, commission payable, and profit-share

£16.6m

£17.2m

 

Profit before tax

£8.8m

£7.2m

 

Profit after tax

£6.5m

£5.2m

 

Profit per share, basic

26.1p

20.7p

 

Profit per share, diluted

25.7p

20.6p

 

 

Financials - consolidated income statement

 

 

£'000

Year to

30 June

2015

13 months

to 30 June

2014

 

Fee income

25,356

24,215

 

Interest & other

65

244

 

Commissions payable

(2,275)

(3,068)

 

Custody & Administration

(738)

(845)

 

Total net income

22,408

20,546

 

Costs:

Human resources

6,250

6,559

 

Premises

634

671

 

Communications & IT

1,376

1,464

 

Business development

499

529

 

General

686

1,075

 

Total costs

9,445

10,298

 

Operating profit

12,963

10,248

 

Profit-share

4,171

3,005

 

Pre-tax profit

8,792

7,243

 

Tax

(2,302)

(2,043)

 

Post-tax profit

6,490

5,200

 

Dividends (prior year final plus current period interim)

(5,960)

(6,031)

 

Retained/(Used)

530

(831)

 

 

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/0664T_1-2015-7-14.pdf 

 

Assumptions:

- Starting point Current FuM (end June 2015)

- Net new money in 2015/2016 (straight-lined to June 2016):

emerging market strategies $250m

diversification strategies $250m

- Operating margin adjusted monthly for change in product mix and commission run-off

- Market growth: 0%

- Increase in overhead: 8%

- Corporation tax based on an estimated average rate of 25%

- Exchange rate assumed to be £1/$1.55 for entire period

- Number of CLIG Shares in issue (27.0m) less those held by the ESOP Trust (2.0m) as at 30 June 2015

 

This can also be found on our website at: http://www.citlon.co.uk/shareholders/announcements.php

 

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin R Green

Canaccord Genuity Limited

Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFMEELFISEEW
Date   Source Headline
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE
23rd May 20244:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.